Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on RSS
Research ArticleArticle

Timing and Magnitude of Initial Change in Disease Activity Score 28 Predicts the Likelihood of Achieving Low Disease Activity at 1 Year in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol: A Post-hoc Analysis of the RAPID 1 Trial

DÉSIRÉE VAN DER HEIJDE, EDWARD C. KEYSTONE, JEFFREY R. CURTIS, ROBERT B. LANDEWÉ, MICHAEL H. SCHIFF, DINESH KHANNA, TORE K. KVIEN, LUCIAN IONESCU, LEON M. GERVITZ, OWEN R. DAVIES, KRISTEL LUIJTENS and DANIEL E. FURST
The Journal of Rheumatology July 2012, 39 (7) 1326-1333; DOI: https://doi.org/10.3899/jrheum.111171
DÉSIRÉE VAN DER HEIJDE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: d.vanderheijde@kpnplanet.nl
EDWARD C. KEYSTONE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JEFFREY R. CURTIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERT B. LANDEWÉ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHAEL H. SCHIFF
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DINESH KHANNA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TORE K. KVIEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LUCIAN IONESCU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LEON M. GERVITZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OWEN R. DAVIES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KRISTEL LUIJTENS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DANIEL E. FURST
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 39 no. 7 1326-1333
DOI 
https://doi.org/10.3899/jrheum.111171
PubMed 
22589265

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Accepted for publication March 21, 2012
  • Published online July 1, 2012.

Article Versions

  • Latest version (May 15, 2012 - 04:01).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2012

Author Information

  1. DÉSIRÉE VAN DER HEIJDE⇓,
  2. EDWARD C. KEYSTONE,
  3. JEFFREY R. CURTIS,
  4. ROBERT B. LANDEWÉ,
  5. MICHAEL H. SCHIFF,
  6. DINESH KHANNA,
  7. TORE K. KVIEN,
  8. LUCIAN IONESCU,
  9. LEON M. GERVITZ,
  10. OWEN R. DAVIES,
  11. KRISTEL LUIJTENS and
  12. DANIEL E. FURST
  1. From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Rebecca MacDonald Center for Arthritis and Autoimmune Disease, Mount Sinai Hospital, Toronto, Ontario, Canada; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Academic Medical Center/University of Amsterdam and Atrium Medical Center, Heerlen, The Netherlands; Rheumatology Division, University of Colorado School of Medicine, Denver, Colorado, USA; Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; UCB Pharma, Brussels, Belgium; UCB Pharma, Smyrna, Georgia, USA; and Division of Rheumatology, UCLA, Los Angeles, California, USA.
  2. D. van der Heijde, MD, PhD, Professor, Department of Rheumatology, Leiden University Medical Center; E.C. Keystone, MD, FRCPC, Professor of Medicine, University of Toronto; J.R. Curtis, MD, Associate Professor of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; R.B. Landewé, MD, PhD, Professor, Academic Medical Center/University of Amsterdam and Atrium Medical Center; M.H. Schiff, MD, Clinical Professor of Medicine, Rheumatology Division, University of Colorado School of Medicine; D. Khanna, MD, MS, Associate Professor of Medicine, Division of Rheumatology, University of Michigan; T.K. Kvien, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital; L. Ionescu, MD, UCB Pharma; L.M. Gervitz, PhD, UCB Pharma; O. Davies, PhD, UCB Pharma; K. Luijtens, PhD, UCB Pharma; D.E. Furst, MD, Carl M. Pearson Professor of Rheumatology, Division of Rheumatology, UCLA.
  1. Address correspondence to Prof. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. E-mail: d.vanderheijde{at}kpnplanet.nl

Article usage

Article usage: May 2012 to January 2021

AbstractFullPdf
May 20122860174
Jun 2012129356
Jul 2012116134100
Aug 20122211830
Sep 20121401826
Oct 20121412134
Nov 2012862524
Dec 2012701619
Jan 20132322323
Feb 20131031218
Mar 2013701829
Apr 2013661514
May 2013401816
Jun 20132867
Jul 20132268
Aug 20132634
Sep 201333911
Oct 20133188
Nov 2013181214
Dec 20132087
Jan 20142755
Feb 2014421213
Mar 201414128
Apr 20141267
May 201414109
Jun 20141936
Jul 201433812
Aug 2014955
Sep 20142678
Oct 20142368
Nov 20141457
Dec 20142526
Jan 20151977
Feb 20151442
Mar 201528810
Apr 20152469
May 20152633
Jun 20151734
Jul 20151235
Aug 20151024
Sep 20154247
Oct 20152444
Nov 2015733
Dec 20157847
Jan 20162015
Feb 20162524
Mar 2016451211
Apr 20163445
May 20161403
Jun 20162112
Jul 20162501
Aug 20162154
Sep 20162214
Oct 20161756
Nov 20162055
Dec 20163355
Jan 20174073
Feb 20175281
Mar 2017311610
Apr 20174094
May 201738122
Jun 20175182
Jul 20172990
Aug 2017641111
Sep 20174353
Oct 20175211
Nov 20175972
Dec 201756121
Jan 201843154
Feb 201852113
Mar 20185052
Apr 20185460
May 20185383
Jun 20186482
Jul 20184097
Aug 201815101
Sep 20182611
Oct 20184093
Nov 20185453
Dec 20184800
Jan 20193152
Feb 20193172
Mar 20192973
Apr 201935115
May 20193071
Jun 20192923
Jul 20192433
Aug 20194311
Sep 20192441
Oct 20196754
Nov 20192941
Dec 20192835
Jan 202043222
Feb 20209708
Mar 202073217
Apr 20204229
May 20204277
Jun 20204135
Jul 20205279
Aug 202092611
Sep 2020143111
Oct 20207339
Nov 20208309
Dec 202010584
Jan 20216353

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 39, Issue 7
1 Jul 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Timing and Magnitude of Initial Change in Disease Activity Score 28 Predicts the Likelihood of Achieving Low Disease Activity at 1 Year in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol: A Post-hoc Analysis of the RAPID 1 Trial
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Timing and Magnitude of Initial Change in Disease Activity Score 28 Predicts the Likelihood of Achieving Low Disease Activity at 1 Year in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol: A Post-hoc Analysis of the RAPID 1 Trial
DÉSIRÉE VAN DER HEIJDE, EDWARD C. KEYSTONE, JEFFREY R. CURTIS, ROBERT B. LANDEWÉ, MICHAEL H. SCHIFF, DINESH KHANNA, TORE K. KVIEN, LUCIAN IONESCU, LEON M. GERVITZ, OWEN R. DAVIES, KRISTEL LUIJTENS, DANIEL E. FURST
The Journal of Rheumatology Jul 2012, 39 (7) 1326-1333; DOI: 10.3899/jrheum.111171

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Timing and Magnitude of Initial Change in Disease Activity Score 28 Predicts the Likelihood of Achieving Low Disease Activity at 1 Year in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol: A Post-hoc Analysis of the RAPID 1 Trial
DÉSIRÉE VAN DER HEIJDE, EDWARD C. KEYSTONE, JEFFREY R. CURTIS, ROBERT B. LANDEWÉ, MICHAEL H. SCHIFF, DINESH KHANNA, TORE K. KVIEN, LUCIAN IONESCU, LEON M. GERVITZ, OWEN R. DAVIES, KRISTEL LUIJTENS, DANIEL E. FURST
The Journal of Rheumatology Jul 2012, 39 (7) 1326-1333; DOI: 10.3899/jrheum.111171
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Save to my folders

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgment
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Salivary Gland Focus Score Is Associated With Myocardial Fibrosis in Primary Sjögren Syndrome Assessed by a Cardiac Magnetic Resonance Approach
  • Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting
  • Effect of Stem Cell Injections on Osteoarthritis-related Structural Outcomes: A Systematic Review
Show more Articles

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2016 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire